Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0001213900-25-096683·Lucius Partners LLC
Schedule 13D ownership disclosure
Palomino Laboratories Inc.
Common Stock, $0.0001 par value per share · CUSIP: 000000000
Event date: 2023-10-09
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Matthew Eitner
Shares: 5,000,000.00 · Class: 100%
- Lucius Partners LLCReported CIK 0002002106
Shares: 5,000,000.00 · Class: 100%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-25-096683
- Form type
- SCHEDULE 13D
- Filer
- Lucius Partners LLC
- CIK
- CIK 2002106
- Filed
- Oct 06, 2025
- Reporting period
- Oct 09, 2023
- Description
- Schedule 13D beneficial ownership